Top compounds associated with response to USP17L1


Feature Type Standardized
Nominal ANOVA
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.099 0.04
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.04
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.05
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.05
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.14 0.06
mRNA MS-275 CTRPv2 pan-cancer AAC 0.06 0.06
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.089 0.06
mRNA paclitaxel UHNBreast pan-cancer AAC -0.56 0.06
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.06
Download CSV